Parker B. Francis Distinguished Professor of Medicine, Brigham and Women's Hospital
Pulmonology
Dr. Jeffrey M. Drazen, MD
|
|
Give Review
Jeffrey M. Drazen is an expert in the field of Pulmonology. He researched medicine at Harvard Medical School. Harvard Medical School is a top medical college. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He over the years received 2 awards: "Elected Member" and "Whos Who in Medicine and Healthcare". Jeffrey Drazen is a published physician as well. He has 95 publications published. The latest was: A Division of Medical Communications in an Academic Medical Center's Department of Medicine. Jeffrey Drazen accepts Medicare payments and is registered with Medicare.gov.
Publications
- A Division of Medical Communications in an Academic Medical Center's Department of Medicine.
- Human neutrophil elastase-mediated goblet cell metaplasia is attenuated in TACE-deficient mice.
- Informed Consent and SUPPORT.
- Tissue factor-bearing exosome secretion from human mechanically stimulated bronchial epithelial cells in vitro and in vivo.
- The Politics of Emergency Contraception.
- A step toward personalized asthma treatment.
- International Union of Basic and Clinical Pharmacology. LXXXIV: Leukotriene Receptor Nomenclature, Distribution, and Pathophysiological Functions.
- The naive airway hyperresponsiveness of the A/J mouse is Kit-mediated.
- Asthma treatment guidelines meet the real world.
- Patient organizations and research on rare Diseases.
- Prescriptions, Privacy, and the First Amendment.
- Lysophosphatidic acid stimulates epidermal growth factor-family ectodomain shedding and paracrine signaling from human lung fibroblasts.
- TACE/ADAM17 Mediates Mechanotransduction in Murine Tracheal Epithelial Cells.
- Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma.
- Products at risk.
- The chitinase-like protein YKL-40 is secreted by airway epithelial cells at base line and in response to compressive mechanical stress.
- The Journal from 1812 to 1989 at NEJM.org.
- Sibutramine--another flawed diet pill.
- Toward more uniform conflict disclosures: the updated ICMJE conflict of interest reporting form.
- The New NEJM.org.
- Don't mess with the DSMB.
- Toward more uniform conflict disclosures--the updated ICMJE conflict of interest reporting form.
- Clinical decisions. American Board of Internal Medicine maintenance of certification program--polling results.
- Choosing asthma step-up care.
- Considering recertification.
- Uniform format for disclosure of competing interests in ICMJE journals.
- Genetics and pharmacogenetics of the leukotriene pathway.
- Health care reform 2009 at healthcarereform.nejm.org.
- Tobacco, public health, and the FDA.
- H1N1 influenza A Disease--information for health professionals.
- Risks of long-acting beta-agonists in achieving asthma control.
- The Medical Device Safety Act of 2009.
- The growth of hospitalists and the changing face of primary care.
- Fighting on.
- Physicians and the First Amendment.
- Ezetimibe and cancer--an uncertain association.
- The FDA and tobacco regulation.
- Health of the nation--coverage for all Americans.
- Cardiac transplantation in infants.
- Guns and health.
- Why doctors should worry about preemption.
- Peer review in the balance.
- Full disclosure and the funding of biomedical research.
- Handgun violence, public health, and the law.
- Cholesterol lowering and ezetimibe.
- Physicians and execution.
- Letting the genome out of the bottle--will we get our wish?
- A pivotal medical-device case.
- Statistics in medicine--reporting of subgroup analyses in clinical trials.
- Open clinical trials.
- No child left uncovered.
- Clinical trial registration: looking back and moving ahead.
- Safer drugs for the American people.
- Clinical Decisions. Mild persistent asthma--polling results.
- Rosiglitazone--continued uncertainty about safety.
- Clinical trial registration--looking back and moving ahead.
- Government in medicine.
- Human papillomavirus vaccine--opportunity and challenge.
- Drug-eluting coronary stents--promise and uncertainty.
- Salvation by registration.
- Acorns and inhalers: the Asthma Clinical Research Network.
- Induction of the plasminogen activator system by mechanical stimulation of human bronchial epithelial cells.
- Research replication.
- Retraction: Sudbø J et al. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 2001;344:1270-8 and Sudbø J e...
- Blueprint for a stronger Food and Drug Administration.
- Volunteers at risk.
- The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.
- Expression of concern reaffirmed.
- Expression of concern: Sudbø J et al. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 2001;344:1270-8 and SudbÃ...
- Chronic effects of mechanical force on airways.
- Trial registration report card.
- Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N ...
- A sad day for science at the FDA.
- Patients at risk.
- Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors.
- CD14 tobacco gene-environment interaction modifies asthma severity and immunoglobulin E levels in Latinos with asthma.
- Asthma: one hundred years of treatment and onward.
- Clinical trial registration: a statement from the International Committee of Medical Journal Editors.
- Using every resource to care for our casualties.
- Bronchial epithelial compression regulates epidermal growth factor receptor family ligand expression in an autocrine manner.
- Interacting genetic loci cause airway hyperresponsiveness.
- COX-2 inhibitors--a lesson in unexpected problems.
- Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma.
- Disaster, water, cholera, vaccines, and hope.
- Your health in the 21st century. Getting all the facts on drugs.
- TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids.
- Awake and informed.
- Embryonic stem-cell research--the case for federal funding.
- Presentation of the 2004 Kober Medal to K. Frank Austen.
- Public access to biomedical research.
- Differentiation-dependent responsiveness of bronchial epithelial cells to IL-4/13 stimulation.
- Expression of nitric oxide synthase-2 in the lungs decreases airway resistance and responsiveness.
- The FDA, politics, and plan B.
- Registry research and medical privacy.
Schools
Harvard Medical School
Peter Bent Brigham Hospital
Procedures Preformed
- Ventilation Management
Conditions Treated
- Acidosis
- Bronchitis
- COPD (Chronic Obstructive Pulmonary Disease)
- Emphysema
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- First Health (Coventry Health Care) PPO
- MultiPlan PPO
- PHCS Network PPO
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Elected Member
- Whos Who in Medicine and Healthcare
Education
-
Brigham and Women's Hospital -
Harvard Medical School
Hospital
-
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1003892803 | |
| NPPES Provider LastName | DRAZEN | |
| NPPES Provider FirstName | JEFFREY | |
| NPPES Provider ZIPCode | 021182526 | |
| NPPES Provider State | MA | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 21.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003892803 |
| Last Name Of The Provider | DRAZEN |
| First Name Of The Provider | JEFFREY |
| View All |
Similar Doctors
|
|
Dr. Michael C. Zaslow, MD
 This Doctor is OpenDoctor Recommended.
|